0 CHECKOUT

NRT Smoking Cessation Aids in Australia

  • ID: 342827
  • November 2015
  • Region: Australia
  • 19 Pages
  • Euromonitor International
1 of 3

The highly regulated tobacco environment, antismoking campaigns and the rising price of tobacco in Australia are all contributing to consumers attempting to give up smoking, supporting sales of NRT smoking cessation aids in 2015. In 2013, the government announced an increase to the excise rate on tobacco of 12.5% each year over the next four years, with these increases drawing consumers to lower-priced cigarettes and encouraging consumers to give up smoking.

The NRT Smoking Cessation Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown
2 of 3

NRT SMOKING CESSATION AIDS IN AUSTRALIA

November 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2010-2015
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015
Table 4 Sales of NRT Gum by Flavour: % Value 2010-2015
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2011-2015
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2012-2015
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
Executive Summary
Consumer Health Delivers Positive Value Growth in 2015
Calls for Pharmacy Deregulation
Mergers and Acquisitions Characterise the Competitive Environment
Discount Pharmacies Continue To Increase Presence
Proactive Attitude To Health Is Expected To Support Growth in Consumer Health
Key Trends and Developments
Mergers and Acquisitions Characterise Consumer Health
Wearable Technologies Are Expected To Complement Consumer Health
Harper Review Recommends Pharmacy Deregulation
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
Table 10 Life Expectancy at Birth 2010-2015
Market Data
Table 11 Sales of Consumer Health by Category: Value 2010-2015
Table 12 Sales of Consumer Health by Category: % Value Growth 2010-2015
Table 13 NBO Company Shares of Consumer Health: % Value 2011-2015
Table 14 LBN Brand Shares of Consumer Health: % Value 2012-2015
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2010-2015
Table 16 Distribution of Consumer Health by Format: % Value 2010-2015
Table 17 Distribution of Consumer Health by Format and Category: % Value 2015
Table 18 Forecast Sales of Consumer Health by Category: Value 2015-2020
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2013-2015
Definitions
Sources
Summary 2 Research Sources

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer Inc.
  • Boehringer Ingelheim GmbH